Loading...

Tivity Health

BST:AFN
Snowflake Description

Undervalued with moderate growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
AFN
BST
$871M
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

Tivity Health, Inc. provides fitness and health improvement programs in the United States. The last earnings update was 11 days ago. More info.


Add to Portfolio Compare Print
AFN Share Price and Events
7 Day Returns
-2.1%
BST:AFN
-3.3%
DE Healthcare
-0.2%
DE Market
1 Year Returns
-48.6%
BST:AFN
-24.7%
DE Healthcare
-10.3%
DE Market
AFN Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Tivity Health (AFN) -2.1% -4.2% -12.7% -48.6% - -
DE Healthcare -3.3% -0.7% 2.5% -24.7% -17.1% 37.8%
DE Market -0.2% -2.4% 4% -10.3% 11.2% 10.8%
1 Year Return vs Industry and Market
  • AFN underperformed the Healthcare industry which returned -24.7% over the past year.
  • AFN underperformed the Market in Germany which returned -10.3% over the past year.
Price Volatility
AFN
Industry
5yr Volatility vs Market

AFN Value

 Is Tivity Health undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Tivity Health to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Tivity Health.

BST:AFN Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 8 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 7.8%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for BST:AFN
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.2%
Equity Risk Premium S&P Global 6%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.68
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.684 (1 + (1- 21%) (133.45%))
1.272
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.27
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.23% + (1.272 * 5.96%)
7.81%

Discounted Cash Flow Calculation for BST:AFN using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Tivity Health is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

BST:AFN DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 7.81%)
2019 119.27 Analyst x4 110.63
2020 169.26 Analyst x3 145.63
2021 216.20 Analyst x1 172.54
2022 234.80 Analyst x1 173.82
2023 256.20 Analyst x1 175.92
2024 272.02 Est @ 6.17% 173.25
2025 283.96 Est @ 4.39% 167.76
2026 292.88 Est @ 3.14% 160.50
2027 299.52 Est @ 2.27% 152.25
2028 304.48 Est @ 1.66% 143.56
Present value of next 10 years cash flows $1,575.87
BST:AFN DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= $304.48 × (1 + 0.23%) ÷ (7.81% – 0.23%)
$4,025.89
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $4,025.89 ÷ (1 + 7.81%)10
$1,898.18
BST:AFN Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $1,575.87 + $1,898.18
$3,474.05
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $3,474.05 / 47.70
$72.83
BST:AFN Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in BST:AFN represents 0.91605x of NasdaqGS:TVTY
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.91605x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (USD) x Listing Adjustment Factor
= $ 72.83 x 0.91605
€66.71
Value per share (EUR) From above. €66.71
Current discount Discount to share price of €16.72
= -1 x (€16.72 - €66.71) / €66.71
74.9%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Tivity Health is available for.
Intrinsic value
>50%
Share price is €16.72 vs Future cash flow value of €66.71
Current Discount Checks
For Tivity Health to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Tivity Health's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Tivity Health's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Tivity Health's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Tivity Health's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BST:AFN PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in USD $1.98
NasdaqGS:TVTY Share Price ** NasdaqGS (2019-05-20) in USD $18.25
Germany Healthcare Industry PE Ratio Median Figure of 10 Publicly-Listed Healthcare Companies 36.92x
Germany Market PE Ratio Median Figure of 424 Publicly-Listed Companies 20.17x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Tivity Health.

BST:AFN PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqGS:TVTY Share Price ÷ EPS (both in USD)

= 18.25 ÷ 1.98

9.22x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Tivity Health is good value based on earnings compared to the DE Healthcare industry average.
  • Tivity Health is good value based on earnings compared to the Germany market.
Price based on expected Growth
Does Tivity Health's expected growth come at a high price?
Raw Data
BST:AFN PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 9.22x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 8 Analysts
19.3%per year
Germany Healthcare Industry PEG Ratio Median Figure of 7 Publicly-Listed Healthcare Companies 1.4x
Germany Market PEG Ratio Median Figure of 273 Publicly-Listed Companies 1.53x

*Line of best fit is calculated by linear regression .

BST:AFN PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 9.22x ÷ 19.3%

0.48x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Tivity Health is good value based on expected growth next year.
Price based on value of assets
What value do investors place on Tivity Health's assets?
Raw Data
BST:AFN PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in USD $10.85
NasdaqGS:TVTY Share Price * NasdaqGS (2019-05-20) in USD $18.25
Germany Healthcare Industry PB Ratio Median Figure of 11 Publicly-Listed Healthcare Companies 1.51x
Germany Market PB Ratio Median Figure of 576 Publicly-Listed Companies 1.78x
BST:AFN PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqGS:TVTY Share Price ÷ Book Value per Share (both in USD)

= 18.25 ÷ 10.85

1.68x

* Primary Listing of Tivity Health.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Tivity Health is overvalued based on assets compared to the DE Healthcare industry average.
X
Value checks
We assess Tivity Health's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Tivity Health has a total score of 5/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

AFN Future Performance

 How is Tivity Health expected to perform in the next 1 to 3 years based on estimates from 8 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
19.3%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Tivity Health expected to grow at an attractive rate?
  • Tivity Health's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • Tivity Health's earnings growth is expected to exceed the Germany market average.
  • Tivity Health's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
BST:AFN Future Growth Rates Data Sources
Data Point Source Value (per year)
BST:AFN Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 8 Analysts 19.3%
BST:AFN Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 8 Analysts 13.2%
Germany Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 9.1%
Germany Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 5.9%
Germany Market Earnings Growth Rate Market Cap Weighted Average 13.1%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BST:AFN Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 8 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BST:AFN Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31 1,753 1
2022-12-31 1,638 1
2021-12-31 1,472 102 2
2020-12-31 1,353 160 103 7
2019-12-31 1,165 94 74 8
BST:AFN Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-03-31 670 102 81
2018-12-31 606 109 98
2018-09-30 593 106 78
2018-06-30 579 107 73
2018-03-31 566 115 67
2017-12-31 557 105 61
2017-09-30 543 101 65
2017-06-30 530 56 50
2017-03-31 516 43 52
2016-12-31 501 47 56
2016-09-30 490 41 53
2016-06-30 478 63 61

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Tivity Health's earnings are expected to grow by 19.3% yearly, however this is not considered high growth (20% yearly).
  • Tivity Health's revenue is expected to grow by 13.2% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BST:AFN Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 8 Analyst Estimates (S&P Global) See Below

All data from Tivity Health Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BST:AFN Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31 1.95 1.95 1.95 1.00
2020-12-31 2.10 2.63 1.71 6.00
2019-12-31 1.55 2.03 1.39 6.00
BST:AFN Past Financials Data
Date (Data in USD Millions) EPS *
2019-03-31 1.98
2018-12-31 2.44
2018-09-30 1.96
2018-06-30 1.83
2018-03-31 1.70
2017-12-31 1.56
2017-09-30 1.66
2017-06-30 1.29
2017-03-31 1.38
2016-12-31 1.50
2016-09-30 1.45
2016-06-30 1.69

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Tivity Health will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Tivity Health's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Tivity Health has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

AFN Past Performance

  How has Tivity Health performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Tivity Health's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Tivity Health has delivered over 20% year on year earnings growth in the past 5 years.
  • Tivity Health's 1-year earnings growth is less than its 5-year average (20.4% vs 36.3%)
  • Tivity Health's earnings growth has exceeded the DE Healthcare industry average in the past year (20.4% vs 4.7%).
Earnings and Revenue History
Tivity Health's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Tivity Health Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BST:AFN Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 670.46 80.78 55.48
2018-12-31 606.30 97.90 31.81
2018-09-30 592.62 78.00 37.02
2018-06-30 578.85 72.53 37.04
2018-03-31 565.90 67.09 37.46
2017-12-31 556.94 61.23 34.36
2017-09-30 542.52 64.73 33.93
2017-06-30 529.87 49.56 36.50
2017-03-31 515.96 52.18 38.43
2016-12-31 501.00 55.60 39.48
2016-09-30 489.55 52.66 38.96
2016-06-30 478.03 61.02 34.97
2016-03-31 466.46 52.22 37.24
2015-12-31 452.09 44.01 35.55
2015-09-30 537.75 37.39 42.80
2015-06-30 609.87 26.29 52.14
2015-03-31 677.06 14.72 56.66
2014-12-31 405.26 42.84 32.08
2014-09-30 712.28 -13.43 66.48
2014-06-30 693.24 -13.60 67.16
2014-03-31 674.90 -14.19 64.54
2013-12-31 663.29 -8.54 61.21
2013-09-30 669.23 -2.65 61.25
2013-06-30 669.17 0.58 59.54
2013-03-31 677.12 6.74 60.25
2012-12-31 677.17 8.02 60.89
2012-09-30 681.99 -169.65 58.57
2012-06-30 691.63 -165.22 58.03

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Tivity Health has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Tivity Health used its assets more efficiently than the DE Healthcare industry average last year based on Return on Assets.
  • Tivity Health's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Tivity Health's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Tivity Health has a total score of 3/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

AFN Health

 How is Tivity Health's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Tivity Health's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Tivity Health's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Tivity Health's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Tivity Health's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Tivity Health Company Filings, last reported 1 month ago.

BST:AFN Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 517.16 1,161.81 18.79
2018-12-31 369.00 30.65 1.93
2018-09-30 346.58 52.18 1.64
2018-06-30 319.86 150.01 67.00
2018-03-31 294.58 147.83 38.79
2017-12-31 271.95 145.96 28.44
2017-09-30 262.69 149.02 4.91
2017-06-30 234.01 182.39 7.80
2017-03-31 213.97 207.30 0.66
2016-12-31 189.30 210.34 1.60
2016-09-30 162.57 250.55 0.73
2016-06-30 96.34 225.88 4.64
2016-03-31 269.37 229.75 3.09
2015-12-31 280.59 231.99 0.23
2015-09-30 296.09 252.45 1.77
2015-06-30 304.46 253.77 5.27
2015-03-31 304.06 263.85 3.75
2014-12-31 304.59 252.12 1.77
2014-09-30 299.31 257.46 1.71
2014-06-30 297.89 253.34 2.43
2014-03-31 294.87 263.39 2.16
2013-12-31 302.69 252.43 2.58
2013-09-30 307.21 261.37 2.82
2013-06-30 278.75 267.95 2.25
2013-03-31 276.24 271.21 2.38
2012-12-31 278.82 293.30 1.76
2012-09-30 276.50 297.36 2.57
2012-06-30 266.83 298.89 1.32
  • Tivity Health's level of debt (224.7%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (89.3% vs 224.7% today).
  • Debt is not well covered by operating cash flow (8.7%, less than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 10.8x coverage).
X
Financial health checks
We assess Tivity Health's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Tivity Health has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

AFN Dividends

 What is Tivity Health's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Tivity Health dividends.
If you bought €2,000 of Tivity Health shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Tivity Health's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Tivity Health's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BST:AFN Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 8 Analyst Estimates (S&P Global) See Below
Germany Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 9 Stocks 1.6%
Germany Market Average Dividend Yield Market Cap Weighted Average of 326 Stocks 3.1%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.5%
Germany Top 25% Dividend Yield 75th Percentile 3.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

BST:AFN Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Tivity Health has not reported any payouts.
  • Unable to verify if Tivity Health's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Tivity Health's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Tivity Health has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Tivity Health's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Tivity Health afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Tivity Health has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

AFN Management

 What is the CEO of Tivity Health's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Donato Tramuto
COMPENSATION $1,146,622
AGE 61
TENURE AS CEO 3.5 years
CEO Bio

Mr. Donato J. Tramuto has been the Chief Executive Officer at Tivity Health, Inc. since November 1, 2015. Mr. Tramuto served as the President of Tivity Health, Inc. since November 1, 2015 until December 26, 2015 and Chairman from June 12, 2014 to 2015. He founded Aptus Health, Inc. in 1995 and served as its Chief Executive Officer. He has more than 30 years of healthcare experience in both the product and service segments. He is an elected official in the State of Maine, winning his first term on a write-in campaign and winning his second term in 2009. He co founded Protocare, Inc., where he served as Chief Executive and President of the Protocare Sciences Division and Corporate Officer of Protocare from 1998 to 2003. He served as Corporate Vice President of Marketing/Healthcare at Caremark, where he helped create its first disease management program for HIV/AIDS. Mr. Tramuto is an elected official in the State of Maine having won his first term on a write-in campaign and winning his second term in 2009. He works closely with the Governor of Maine on healthcare issues. He was appointed by the Governor of Maine to a 3-year term on the Maine Economic Growth Council. He serves as the Chairman of the Donato J. Tramuto Foundation that he founded in 2001 to help disadvantaged youth reach their educational goals. Since 2014, he has served as Chairman of RFK Human Rights, where he led efforts to support the work of it, getting human rights education and advocacy programs to schools and communities around the world. He serves on RFK Human Rights Leadership Board. He served as the Chairman of Aptus Health, Inc. since September 24, 2013 until July 27, 2016 and served as its Vice Chairman until September 24, 2013. He serves as a Director at Tomorrow Networks, LLC and MedManage Systems, Inc. Mr. Tramuto has been a Director of Sharecare, Inc. since 2016, Tivity Health, Inc. since June 2013 and Robert F. Kennedy Center for Justice & Human Rights since July 2016. In 2012, he was appointed to the Board of RFK Human Rights Europe because of his expertise and strategic leadership in global health, including his proven ability to develop and implement healthcare solutions in countries with underserved communities. He serves on several executive leadership boards: the Duke University Fuqua Health Care Advisory Board, the Regis College Board of Trustees and the Sample MD Board of Directors. He served as a Director of Aptus Health, Inc. until July 27, 2016. Mr. Tramuto was twice selected by PharmaVoice as one of the Top 100 Most Inspirational Healthcare Leaders in the Life Sciences Industry (2005, 2009 and 2012). He co-founded the not-for-profit program Heath eVillages, a program helping third world countries address healthcare issues via the use of handheld mobile devices. Mr. Tramuto is a well-known and sought after speaker on issues pertaining to healthcare access and quality. In May 2012, he was recognized by The Boston Globe as one the top 12 innovators in Massachusetts for his work on Health eVillages.

CEO Compensation
  • Donato's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Donato's remuneration is about average for companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the Tivity Health management team in years:

1.9
Average Tenure
52
Average Age
  • The average tenure for the Tivity Health management team is less than 2 years, this suggests a new team.
Management Team

Donato Tramuto

TITLE
CEO & Director
COMPENSATION
$1M
AGE
61
TENURE
3.5 yrs

Adam Holland

TITLE
Chief Financial Officer
COMPENSATION
$805K
AGE
39
TENURE
1.9 yrs

Ryan Wagers

TITLE
Chief Accounting Officer & Controller
COMPENSATION
$105K
AGE
40
TENURE
0.6 yrs

Mary Flipse

TITLE
Chief Legal & Administrative Officer
COMPENSATION
$470K
AGE
51
TENURE
1.8 yrs

Steve Janicak

TITLE
President of Fitness Division & Division President of Healthcare
COMPENSATION
$515K
AGE
58
TENURE
0.3 yrs

Dawn Zier

TITLE
President
AGE
53
TENURE
0.2 yrs

Paul Edmisten

TITLE
Chief Information Officer
TENURE
2.7 yrs

Tommy Lewis

TITLE
Senior Vice President of Investor Relations & Transformation

Bonnie Schirato

TITLE
Vice President of People & Culture

Janet Calhoun

TITLE
Chief Experience Officer
TENURE
2.5 yrs
Board of Directors Tenure

Average tenure and age of the Tivity Health board of directors in years:

3.8
Average Tenure
56.5
Average Age
  • The tenure for the Tivity Health board of directors is about average.
Board of Directors

Kevin Wills

TITLE
Independent Chairman
COMPENSATION
$310K
AGE
52
TENURE
3.5 yrs

Donato Tramuto

TITLE
CEO & Director
COMPENSATION
$1M
AGE
61
TENURE
5.9 yrs

Dawn Zier

TITLE
President
AGE
53
TENURE
0.2 yrs

Brad Karro

TITLE
Director
COMPENSATION
$215K
AGE
56
TENURE
4.9 yrs

Bob Greczyn

TITLE
Director
COMPENSATION
$215K
AGE
66
TENURE
4 yrs

Lee Shapiro

TITLE
Director
COMPENSATION
$225K
AGE
62
TENURE
4 yrs

Paul Keckley

TITLE
Director
COMPENSATION
$211K
AGE
68
TENURE
4.9 yrs

Archelle Georgiou

TITLE
Director
COMPENSATION
$213K
AGE
56
TENURE
3 yrs

Pete Hudson

TITLE
Director
COMPENSATION
$211K
AGE
52
TENURE
3 yrs

Sara Finley

TITLE
Director
COMPENSATION
$165K
AGE
57
TENURE
1 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Tivity Health insiders in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
22. Mar 19 Buy Paul Keckley Individual 21. Mar 19 21. Mar 19 5,780 €15.28 €88,338
22. Mar 19 Buy Bradley Karro Individual 22. Mar 19 22. Mar 19 2,900 €14.64 €42,469
22. Mar 19 Buy Robert Greczyn Individual 20. Mar 19 20. Mar 19 5,810 €15.15 €88,010
22. Mar 19 Buy Lee Shapiro Individual 20. Mar 19 20. Mar 19 4,050 €15.68 €63,490
22. Mar 19 Buy Benjamin Kirshner Individual 20. Mar 19 20. Mar 19 14,569 €15.20 €221,462
22. Mar 19 Buy Sara Finley Individual 20. Mar 19 20. Mar 19 2,000 €15.19 €30,384
X
Management checks
We assess Tivity Health's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Tivity Health has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

AFN News

Simply Wall St News

AFN Company Info

Description

Tivity Health, Inc. provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers. It also provides health plans through WholeHealth Living program; and health services, such as chiropractic care, acupuncture, physical therapy, occupational therapy, speech therapy, and others. The company was formerly known as Healthways, Inc. and changed its name to Tivity Health, Inc. in January 2017. Tivity Health, Inc. was founded in 1981 and is headquartered in Franklin, Tennessee.

Details
Name: Tivity Health, Inc.
AFN
Exchange: BST
Founded: 1981
$779,244,597
47,702,306
Website: http://www.tivityhealth.com
Address: Tivity Health, Inc.
701 Cool Springs Boulevard,
Franklin,
Tennessee, 37067,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqGS TVTY Common Stock Nasdaq Global Select US USD 13. Aug 1991
BST AFN Common Stock Boerse-Stuttgart DE EUR 13. Aug 1991
Number of employees
Current staff
Staff numbers
500
Tivity Health employees.
Industry
Health Care Services
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/20 22:37
End of day share price update: 2019/05/20 00:00
Last estimates confirmation: 2019/05/17
Last earnings filing: 2019/05/09
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.